New England Journal of Medicine · 1998 · 795 citations · 22 references
Metformin and troglitazone have equal and additive beneficial effects on glycemic control in patients with type 2 diabetes. Metformin acts primarily by decreasing endogenous glucose production, and troglitazone by increasing the rate of peripheral glucose disposal.
22
Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus
Michael Stümvoll, N. Nurjhan, G. Perriello et al. · New England Journal of Medicine · 1995 · 1.1K citations · Full text